Similar articles

• Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.

  Ahmed MS, Jacques LC, Mahallawi W, Ferrara F, Temperton N, Upile N, Vaughan C, Sharma R, Beer H, Hoschler K, McNamara PS, Zhang Q. Ahmed MS, et al. Antiviral Res. 2015 Feb;114:106-12. doi: 10.1016/j.antiviral.2014.12.008. Epub 2014 Dec 13. Antiviral Res. 2015. PMID: 25513756
• [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].

  Shen HH, Hou J, Zhao M, Xu J, Bai BK, Zhao J, Hu Y, Mao PY, Li BA, Mao YL. Shen HH, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Aug;26(4):270-2. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012. PMID: 23189841 Chinese.
• Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1).

  Barrett PN, Ehrlich HJ. Barrett PN, et al. Lancet Infect Dis. 2011 Jul;11(7):496-7; author reply 497-8. doi: 10.1016/S1473-3099(11)70155-4. Lancet Infect Dis. 2011. PMID: 21700237 No abstract available.
• Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.

  Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y. Skowronski DM, et al. J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17. J Infect Dis. 2015. PMID: 25784728
• A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.

  Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM. Lu CC, et al. Vaccine. 2011 Jan 10;29(3):444-50. doi: 10.1016/j.vaccine.2010.10.081. Epub 2010 Nov 13. Vaccine. 2011. PMID: 21078406